chr15-80153101-A-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000137.4(FAH):c.47A>T(p.Asn16Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000137.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAH | NM_000137.4 | c.47A>T | p.Asn16Ile | missense_variant | Exon 1 of 14 | ENST00000561421.6 | NP_000128.1 | |
FAH | NM_001374377.1 | c.47A>T | p.Asn16Ile | missense_variant | Exon 2 of 15 | NP_001361306.1 | ||
FAH | NM_001374380.1 | c.47A>T | p.Asn16Ile | missense_variant | Exon 2 of 15 | NP_001361309.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151460Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251278Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135828
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461652Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727142
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151460Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73924
ClinVar
Submissions by phenotype
Tyrosinemia type I Pathogenic:3
Variant summary: FAH c.47A>T (p.Asn16Ile) results in a non-conservative amino acid change to a highly conserved residue (HGMD) located in the Fumarylacetoacetase, N-terminal (IPR015377) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251278 control chromosomes (gnomAD). c.47A>T has been reported in the literature in an individual affected with Tyrosinemia Type 1 (Phaneuf_1992). These data suggest the variant may be associated with disease. At least three publications report experimental evidence evaluating an impact on protein function, finding that the variant protein lacks enzymatic activity and shows aberrant aggregation in the insoluble fraction of cells (Phaneuf_1992, Bergeron_2001, Macias_2019). The following publications have been ascertained in the context of this evaluation (PMID: 1401056, 11278491, 31300554). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at